Advances in the treatment of prolactinomas.

  title={Advances in the treatment of prolactinomas.},
  author={Mary P. Gillam and Mark E Molitch and Gaetano Lombardi and Annamaria Colao},
  journal={Endocrine reviews},
  volume={27 5},
Prolactinomas account for approximately 40% of all pituitary adenomas and are an important cause of hypogonadism and infertility. The ultimate goal of therapy for prolactinomas is restoration or achievement of eugonadism through the normalization of hyperprolactinemia and control of tumor mass. Medical therapy with dopamine agonists is highly effective in the majority of cases and represents the mainstay of therapy. Recent data indicating successful withdrawal of these agents in a subset of… CONTINUE READING
Highly Influential
This paper has highly influenced 20 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS

From This Paper

Topics from this paper.
187 Citations
2 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 187 extracted citations


Publications referenced by this paper.
Showing 1-2 of 2 references

A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea . Cabergoline Comparative Study Group

  • HM Connolly, JL Crary, +7 authors MF Scanlon
  • N Engl J Med
  • 1994

Similar Papers

Loading similar papers…